Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

3061 - 3070 of 3456 results found

Sysadoas. Condroprotectores en el tratamiento de la artrosis (Informe nº: Osteba E-14-08)

MeSH Terms
Chondroitin Sulfates (D09.698.373.200.300); Safety (N06.850.135.060.075); Osteoarthritis (C05.550.114.606); Glucosamine (D09.067.342.531)
Guideline Contact
Iñaki Gutierrez-Ibarluzea (igutierrezibarluzea@bioef.org)
English Title Translation
Sysadoas. Chondroprotective drugs in the treatment of arthritis
Publication Scope
assessment
treatment
Countries of Application
Spain
Guideline Publication Status
Published
Languages
Spanish
Authors
OSTEBA (ES)
Publication Year
2014

Systemic therapy for acute lymphoblastic leukemia (ALL)

MeSH Terms

Daunorubicin (D02.455.426.559.847.562.050.200); Precursor Cell Lymphoblastic Leukemia-Lymphoma (C15.604.515.560.600); Cyclophosphamide (D02.455.526.728.650.730.243); Cytarabine (D03.383.742.680.245.453)

Guideline Contact
Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2016

Systemic Therapy for Advanced Gastric and Gastro-Esophageal Carcinoma

MeSH Terms
stomach, gastric, gastroesophogeal, neoplasia, carcinoma, cancer, tumor, metastatic, malignancy, recurrent, advanced
Guideline Contact
Chika Arinze; pebconc@mcmaster.ca
Keywords
stomach, gastric, gastroesophogeal, neoplasia, cancer, recurrent, advanced
Date for Review
In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date
2022-08-31
Date of Last Evidence Search
Jul-21
Methods Applied
Systematic review-based, Externally reviewed, Evidence quality assessment, GRADE approach
Publication Scope
Guidelines
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
PEBC (Program in evidenced-based care)
Publication Year
2022

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline

MeSH Terms
Carcinoma; Hepatocellular (C04.588.274.623.160) Neoplasms (C04)
  • Neoplasms by Site (C04.588)
    • Digestive System Neoplasms (C04.588.274)
      • Liver Neoplasms (C04.588.274.623)
        • Carcinoma, Hepatocellular (C04.588.274.623.160)
Guideline Contact
guidelines@asco.org
Date for Review
22-Nov
Publication Date
16-Nov-20
Date of Last Evidence Search
15-May-20
Publication Scope
treatment
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ASCO (US)
Publication Year
2020

Systemic therapy for advanced or recurrent endometrial cancer, and advanced or recurrent uterine papillary serous carcinoma

MeSH Terms

Endometrial Neoplasms (C04.588.945.418.948.585); Uterine Neoplasms (C04.588.945.418.948); Drug Therapy (E02.319); Drug Therapy; Combination (E02.319.310); Antineoplastic Agents (D27.505.954.248)

Guideline Contact
Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2017

Systemic Therapy for Melanoma: ASCO Guideline

MeSH Terms
Melanoma (C04.557.465.625.650.510)
Guideline Contact
guidelines@asco.org
Publication Date
31-Mar-20
Publication Scope
treatment
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ASCO (US)
Publication Year
2020

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Guideline Contact
Judy Brown; pebconc@mcmaster.ca
Date for Review
In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date
09/08/2022
Publication Scope
Guidelines
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Publication Year
2022

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update

MeSH Terms
Neoplasms (C04); Breast Neoplasms (C04.588.180); Pharmacologic Actions (D27.505)
Guideline Contact
guidelines@asco.org
Publication Date
25-Jun-18
Publication Scope
prognosis
treatment
Countries of Application
United States
Guideline Publication Status
Under Review
Languages
English
Authors
ASCO (US)
Publication Year
2018